SARS-CoV-2-IN-105
SARS-CoV-2-IN-105 (Compound 4a) is a SARS-CoV-2 inhibitor with the EC50 of 0.69 μM[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(NC1=CC(Cl)=CC(Cl)=C1)C2=NNC3=CC=C(Cl)C=C32
Molecular Formula
C14H8Cl3N3O
Molecular Weight
340.59
References & Citations
[1]Lee JY, et al. Synthesis and evaluation of N-arylindazole-3-carboxamide derivatives as novel antiviral agents against SARS-CoV-2. Bioorg Med Chem Lett. 2024 Dec 1;114:130015.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
